Ascendis Pharma
Creating more effective drugs
Ascendis Pharma has raised €48M across 1 funding round from 2 investors, most recently a Series C round in Dec 2014. Based in Hellerup, Denmark; active in Healthtech. Data as of 4 Nov 2026.
Hellerup, Denmarkwww.ascendispharma.com ↗
Total raised
€48M
€48,065,369
Funding rounds
1
Investors
2
distinct backers
Active since
2014-12
latest 2014-12
Funding by year
EUR raised per yearAscendis Pharma — funding by year — interactive chart.
Data table
| Ascendis Pharma — funding by year | |
|---|---|
| 2014 | €48M |
Signals
High confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-12-01 | Series C | €48M | Sofinnova Partners,Venrock | View deal → |
Investors
2Similar companies
same sector, similar size- Orphazyme€34MDenmark · Healthtech
- Galecto Biotech€79MDenmark · Healthtech
- Auris Medical€46MSwitzerland · Healthtech
- STAT-Diagnostica€49MSpain · Healthtech
- Endosense€59MSwitzerland · Healthtech
- Biom'Up€38MFrance · Healthtech
Global coverage: FundingData